Idiopathic Hypersomnia

Synonyms

IH,

Overview

Idiopathic Hypersomnia (IH) is a chronic, neurological sleep disorder characterized by severe, excessive daytime sleepiness (EDS) despite adequate or long, unrefreshing nocturnal sleep. “Idiopathic” means the cause is unknown, and symptoms typically include profound sleep inertia (difficulty waking), long naps that do not relieve tiredness, and cognitive impairment (brain fog).

Symptoms

IH is a chronic neurological disorder characterized by severe, constant daytime sleepiness despite long, unrefreshing sleep. Key symptoms include 10+ hours of sleep, severe “sleep drunkenness” (difficult waking), unrefreshing long naps, and cognitive impairment (“brain fog”). Symptoms typically begin between ages 10 and 30 and are not relieved by extra sleep.

Causes

As “idiopathic” implies, the exact cause is unknown, though research points toward chemical imbalances in the brain, genetic factors, and potential autoimmune dysfunction that disrupt wakefulness.

Prevention

Because the cause of idiopathic hypersomnia (IH) is unknown, it cannot be prevented, but its symptoms can be managed through a strict, consistent sleep schedule, avoiding alcohol and caffeine, and reducing stress. Lifestyle management—including regular, light exercise, a healthy diet, and creating a dark, cool, and quiet sleep environment—is crucial for reducing daytime fatigue.

Diagnosis

Idiopathic Hypersomnia (IH) is diagnosed by a sleep specialist based on chronic, excessive daytime sleepiness (lasting $\ge$3 months) despite long or adequate sleep, typically confirmed via overnight polysomnography (PSG) and a next-day Multiple Sleep Latency Test (MSLT). The diagnosis requires ruling out other causes of sleepiness (e.g., sleep apnea, insufficient sleep).

Prognosis

While there is no cure, symptoms can be managed with medication, and in rare cases, spontaneous remission occurs (10–20% of cases). Most patients experience stable symptoms over time, requiring long-term treatment to improve daily functioning.

Treatment

Treatment focuses on managing excessive daytime sleepiness and severe sleep inertia, primarily using wakefulness-promoting medications. Low-sodium oxybate (Xywav) is the only FDA-approved treatment specifically for IH in adults, while others like modafinil, armodafinil, and stimulants are commonly used off-label.